George Stewart
Allergy & Immunology · Ocala, FLNPI 1275538795
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,800 of the $14,693 with a category attached, or 73.5%. GSK accounts for 81.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $6,448 and has fallen 99.1% since, to $60 in 2023.
Across 109 payments — averaging $134.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$12K
- AstraZeneca$735
- Sanofi$425
- Covis Pharma GmbH$301
- Boehringer Ingelheim$261
- Novartis$246
- plus $783 from 12 others
Across 11 payments — averaging $7718.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$77K
- GSK$5K
- Teva Pharmaceuticals USA, Inc.$1K
- Novartis$1K
What the payments were for
- Speaking & faculty fees$10,80074%
- Food & beverage$3,87826%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 30 | $11,941 |
| AstraZeneca | 10 | $735 |
| Sanofi | 14 | $425 |
| Covis Pharma GmbH | 15 | $301 |
| Boehringer Ingelheim | 3 | $261 |
| Novartis | 11 | $246 |
| Grifols USA, LLC | 2 | $148 |
| Pfizer | 2 | $105 |
| Optinose US, Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 1 | $83 |
| CSL Behring | 2 | $79 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Biocryst US Sales Co., LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| AbbVie | 2 | $38 |
| Pharming Healthcare, Inc. | 2 | $33 |
| USWM, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$11,166
- NUCALA$475
- TEZSPIRE$129
- Prolastin-C Liquid$125
- DUPIXENT$124
- BREZTRI$108
- FASENRA$100
How this compares
$14,693 in reported general payments places this provider in the 75th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Ocala
- Dennis LedfordTampa$1.2M
- Nina RamirezMiami$833K
- Thomas WestbrookPensacola$810K
- Shahnaz FattehPlantation$677K
- Thomas CasaleTampa$382K
- Thomas JohnsonGainesville$361K
- Mark GlaumTampa$337K
- Alan HalseyValrico$243K
- Steve DormanJacksonville$208K
- Juan Carlos CardetTampa$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.